{"id":"NCT00883493","sponsor":"AstraZeneca","briefTitle":"Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression","officialTitle":"A Randomised, Multi-Centre Study to Compare the Efficacy and Safety of Extended Release Quetiapine Fumarate (Seroquel XR TM) Tablets as Mono-Therapy or in Combination With Lithium in the Treatment of Patients With Acute Bipolar Depression","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-04","primaryCompletion":"2011-03","completion":"2011-03","firstPosted":"2009-04-17","resultsPosted":"2012-06-29","lastUpdate":"2012-07-11"},"enrollment":421,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Bipolar Depression"],"interventions":[{"type":"DRUG","name":"Quetiapine fumarate XR","otherNames":["SEROQUEL XR"]},{"type":"DRUG","name":"Lithium carbonate","otherNames":["LITHURIL Tb in TURKEY","LITOCARB in PERU"]}],"arms":[{"label":"Quetiapin fumarate XR","type":"EXPERIMENTAL"},{"label":"Quetiapin fumarate XR+Lithium carbonate","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to compare the efficacy of quetiapine fumarate monotherapy with quetiapine fumarate in combination with lithium in the treatment of a major depressive episode in patients with bipolar disorder.","primaryOutcome":{"measure":"Change in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score.","timeFrame":"Baseline, 8 weeks","effectByArm":[{"arm":"Quetiapine XR","deltaMin":23.7,"sd":8.4},{"arm":"Quatiapine XR + Lithium","deltaMin":24.3,"sd":7.9}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":24,"countries":["Argentina","Brazil","Chile","Colombia","Guatemala","Mexico","Peru","Turkey (TÃ¼rkiye)","Venezuela"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":212},"commonTop":["Dry mouth","Somnolance","Headache","Dizziness","Nausea"]}}